东方财富产品
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-61278686 举报邮箱：jubao@eastmoney.com
| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 451 | 03347 | 泰格医药 | Sands Family Trust, LLC |
增持 | 21.91万 | 1485.85万 | 12.07% | 2021-11-04 |
| 452 | 03347 | 泰格医药 | Sands Capital Management, LP |
增持 | 21.91万 | 1485.85万 | 12.07% | 2021-11-04 |
| 453 | 03347 | 泰格医药 | Sands Capital Management, LLC |
增持 | 21.91万 | 1485.85万 | 12.07% | 2021-11-04 |
| 454 | 03347 | 泰格医药 | F-J Sands Family I, LLC |
增持 | 21.91万 | 1485.85万 | 12.07% | 2021-11-04 |
| 455 | 03347 | 泰格医药 | Citigroup Inc. |
增持 | 6.35万 | 739.06万 | 6.00% | 2021-11-03 |
| 456 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -30.76万 | 1208.93万 | 9.81% | 2021-11-03 |
| 457 | 03347 | 泰格医药 | 2017 Eagle Holdings LLC |
增持 | 73.67万 | 1420.07万 | 11.53% | 2021-11-02 |
| 458 | 03347 | 泰格医药 | Sands Family Trust, LLC |
增持 | 73.67万 | 1420.07万 | 11.53% | 2021-11-02 |
| 459 | 03347 | 泰格医药 | Sands Capital Management, LP |
增持 | 73.67万 | 1420.07万 | 11.53% | 2021-11-02 |
| 460 | 03347 | 泰格医药 | Sands Capital Management, LLC |
增持 | 73.67万 | 1420.07万 | 11.53% | 2021-11-02 |
| 461 | 03347 | 泰格医药 | F-J Sands Family I, LLC |
增持 | 73.67万 | 1420.07万 | 11.53% | 2021-11-02 |
| 462 | 03347 | 泰格医药 | Aggregate of abrdn plc affiliated investment management entities |
增持 | 39.23万 | 652.28万 | 5.30% | 2021-11-01 |
| 463 | 03347 | 泰格医药 | 2017 Eagle Holdings LLC |
增持 | 62.11万 | 1275.95万 | 10.36% | 2021-10-29 |
| 464 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -58.70万 | 108.96万 | 0.88% | 2021-10-29 |
| 465 | 03347 | 泰格医药 | Sands Family Trust, LLC |
增持 | 62.11万 | 1275.95万 | 10.36% | 2021-10-29 |
| 466 | 03347 | 泰格医药 | Sands Capital Management, LP |
增持 | 62.11万 | 1275.95万 | 10.36% | 2021-10-29 |
| 467 | 03347 | 泰格医药 | Sands Capital Management, LLC |
增持 | 62.11万 | 1275.95万 | 10.36% | 2021-10-29 |
| 468 | 03347 | 泰格医药 | F-J Sands Family I, LLC |
增持 | 62.11万 | 1275.95万 | 10.36% | 2021-10-29 |
| 469 | 03347 | 泰格医药 | BlackRock, Inc. |
增持 | 11.84万 | 872.15万 | 7.08% | 2021-10-26 |
| 470 | 03347 | 泰格医药 | Aggregate of abrdn plc affiliated investment management entities |
减持 | -3.47万 | 612.63万 | 4.98% | 2021-10-25 |
| 471 | 03347 | 泰格医药 | NINETY ONE UK LIMITED |
减持 | -2.27万 | 738.18万 | 5.99% | 2021-10-22 |
| 472 | 03347 | 泰格医药 | Aggregate of abrdn plc affiliated investment management entities |
增持 | 1.99万 | 616.10万 | 5.00% | 2021-10-22 |
| 473 | 03347 | 泰格医药 | NINETY ONE UK LIMITED |
增持 | 2.03万 | 740.45万 | 6.01% | 2021-10-21 |
| 474 | 03347 | 泰格医药 | BlackRock, Inc. |
减持 | -4300.00 | 861.72万 | 6.99% | 2021-10-20 |
| 475 | 03347 | 泰格医药 | BlackRock, Inc. |
增持 | 3.31万 | 862.54万 | 7.01% | 2021-10-18 |
| 476 | 03347 | 泰格医药 | Aggregate of abrdn plc affiliated investment management entities |
减持 | -4.50万 | 613.57万 | 4.98% | 2021-10-15 |
| 477 | 03347 | 泰格医药 | BlackRock, Inc. |
减持 | -3.88万 | 859.50万 | 6.98% | 2021-10-14 |
| 478 | 03347 | 泰格医药 | Citigroup Inc. |
增持 | 155.81万 | 735.88万 | 5.97% | 2021-10-13 |
| 479 | 03347 | 泰格医药 | BlackRock, Inc. |
增持 | 16.20万 | 876.18万 | 7.12% | 2021-10-12 |
| 480 | 03347 | 泰格医药 | Citigroup Inc. |
减持 | -158.30万 | 580.07万 | 4.71% | 2021-10-12 |
| 481 | 03347 | 泰格医药 | Citigroup Inc. |
减持 | -8.28万 | 738.37万 | 5.99% | 2021-10-11 |
| 482 | 03347 | 泰格医药 | BlackRock, Inc. |
减持 | -1.79万 | 860.60万 | 6.99% | 2021-10-07 |
| 483 | 03347 | 泰格医药 | Citigroup Inc. |
减持 | -1.55万 | 750.46万 | 6.09% | 2021-10-07 |
| 484 | 03347 | 泰格医药 | NINETY ONE UK LIMITED |
减持 | -7900.00 | 738.49万 | 5.99% | 2021-10-07 |
| 485 | 03347 | 泰格医药 | Citigroup Inc. |
增持 | 1.64万 | 752.00万 | 6.10% | 2021-10-06 |
| 486 | 03347 | 泰格医药 | Citigroup Inc. |
减持 | -2.38万 | 750.36万 | 6.09% | 2021-10-05 |
| 487 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 82.24万 | 160.98万 | 1.30% | 2021-10-04 |
| 488 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -109.24万 | 78.74万 | 0.63% | 2021-09-30 |
| 489 | 03347 | 泰格医药 | NINETY ONE UK LIMITED |
增持 | 11.08万 | 749.58万 | 6.08% | 2021-09-23 |
| 490 | 03347 | 泰格医药 | BAILLIE GIFFORD & CO |
减持 | -4.08万 | 614.90万 | 4.99% | 2021-09-20 |
| 491 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 27.53万 | 1246.95万 | 10.12% | 2021-09-14 |
| 492 | 03347 | 泰格医药 | UBS Group AG |
减持 | -63.38万 | 553.06万 | 4.49% | 2021-09-14 |
| 493 | 03347 | 泰格医药 | UBS Group AG |
增持 | 8.60万 | 616.07万 | 5.00% | 2021-09-13 |
| 494 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 7.57万 | 126.88万 | 1.03% | 2021-09-13 |
| 495 | 03347 | 泰格医药 | Citigroup Inc. |
增持 | 13.43万 | 757.81万 | 6.15% | 2021-09-10 |
| 496 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -13.47万 | 1231.13万 | 9.99% | 2021-09-07 |
| 497 | 03347 | 泰格医药 | Citigroup Inc. |
减持 | -11.41万 | 745.63万 | 6.05% | 2021-09-07 |
| 498 | 03347 | 泰格医药 | Citigroup Inc. |
增持 | 15.20万 | 757.05万 | 6.14% | 2021-09-06 |
| 499 | 03347 | 泰格医药 | BlackRock, Inc. |
减持 | -2.16万 | 983.66万 | 7.99% | 2021-09-03 |
| 500 | 03347 | 泰格医药 | BlackRock, Inc. |
增持 | 2.36万 | 986.35万 | 8.01% | 2021-09-02 |
